RR
Rajuchettair Ramachandran
About Rajuchettair Ramachandran
Data last updated:
Rajuchettair Ramachandran is an Additional Director at United Visa Services Private Limited (since 2025), Managing Director at Rakod Laboratories Private Limited (since 2011) and Director at Amirthaas Medi Therapie Private Limited (since 2025). The companies operate in Transport and Logistics and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹21.47 Cr; the largest is United Visa Services Private Limited at ₹21.28 Cr (FY 2025). Earlier, Rajuchettair Ramachandran was a Managing Director at Zendic (India) Pharmaceuticals Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 United Visa Services Private Limited U63040TN2006PTC059954 | Additional Director | 14 Jun 2025 | 2006 | ₹21.28 Cr (FY 2025) | Active |
| Rakod Laboratories Private Limited U85195TN2002PTC049856 | Managing Director | 09 Apr 2011 | 2002 | ₹18.9 Lakh (FY 2018) | Active |
| Amirthaas Medi Therapie Private Limited U86100TZ2025PTC033306 | Director | 08 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Zendic (India) Pharmaceuticals Private Limited U24232TN2001PTC052857 | Managing Director | 09 Apr 2011 | 2001 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajuchettair Ramachandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Grace Steffy Joyce Arul Lazaran | 10981960 | United Visa Services Private Limited | Additional Director |
| Santhanam Kannan | 02058117 | United Visa Services Private Limited | Director |
| Armuhum | 10187345 | Rakod Laboratories Private Limited | Director |
| Lakshmanan Raju | 03486698 | Rakod Laboratories Private Limited | Director |
| Raju Chettiar Balamurugan | 01118883 | Rakod Laboratories Private Limited | Director |
| Sornavel Rajarathinam | 00926001 | Rakod Laboratories Private Limited | Whole-Time Director |
| Arumugam Siva Kumar | 10900187 | Amirthaas Medi Therapie Private Limited | Director |
| Lakshmana Arumugam | 10900188 | Amirthaas Medi Therapie Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajuchettair Ramachandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajuchettair Ramachandran
Rajuchettair Ramachandran currently holds 3 directorships: United Visa Services Private Limited (Additional Director, since 14 Jun 2025, revenue ₹21.28 Cr (FY 2025)); Rakod Laboratories Private Limited (Managing Director, since 09 Apr 2011, revenue ₹18.9 Lakh (FY 2018)); Amirthaas Medi Therapie Private Limited (Director, since 08 Jan 2025).
Rajuchettair Ramachandran was first appointed on 09 Apr 2011 as Managing Director at Rakod Laboratories Private Limited. The most recent appointment on record is 14 Jun 2025 at United Visa Services Private Limited.
The 2 current companies of Rajuchettair Ramachandran that report revenue have a combined latest revenue of ₹21.47 Cr: United Visa Services Private Limited ₹21.28 Cr (FY 2025); Rakod Laboratories Private Limited ₹18.9 Lakh (FY 2018).
Rajuchettair Ramachandran held 1 earlier board appointment: Zendic (India) Pharmaceuticals Private Limited (Managing Director, from 09 Apr 2011).
The current boards of Rajuchettair Ramachandran's companies include Grace Steffy Joyce Arul Lazaran (United Visa Services Private Limited), Santhanam Kannan (United Visa Services Private Limited), Armuhum (Rakod Laboratories Private Limited), Lakshmanan Raju (Rakod Laboratories Private Limited), Raju Chettiar Balamurugan (Rakod Laboratories Private Limited), Sornavel Rajarathinam (Rakod Laboratories Private Limited), among others.